The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
108536735 10853673 5 F 2016 20160805 20150223 20160815 EXP US-PFIZER INC-2015066233 PFIZER 70.00 YR M Y 121.60000 KG 20160815 MD US US

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
108536735 10853673 1 PS LYRICA PREGABALIN 1 Oral 150 MG, 2X/DAY N17632 21446 150 MG CAPSULE, HARD BID
108536735 10853673 2 SS LYRICA PREGABALIN 1 21446 CAPSULE, HARD
108536735 10853673 3 C TAMSULOSIN TAMSULOSIN 1 Oral 0.4 MG, 1X/DAY(AT NIGHT) 0 .4 MG CAPSULE QD
108536735 10853673 4 C TAMSULOSIN TAMSULOSIN 1 Oral 0.4 MG/XL 0 .4 MG CAPSULE
108536735 10853673 5 C GEMFIBROZIL. GEMFIBROZIL 1 Oral 600 MG, 2X/DAY 0 600 MG BID
108536735 10853673 6 C GEMFIBROZIL. GEMFIBROZIL 1 Oral 400 MG, 1X/DAY 0 400 MG QD
108536735 10853673 7 C LEVOTHYROXIN LEVOTHYROXINE 1 Oral 150 UG, 1X/DAY AT NIGHT 0 150 UG TABLET QD
108536735 10853673 8 C GLIMEPIRIDE. GLIMEPIRIDE 1 Oral 4 MG, 2X/DAY 0 4 MG BID
108536735 10853673 9 C GLIMEPIRIDE. GLIMEPIRIDE 1 Oral 400 MG, 2X/DAY 0 400 MG BID
108536735 10853673 10 C GLIMEPIRIDE. GLIMEPIRIDE 1 Oral 4 MG, DAILY 0 4 MG
108536735 10853673 11 C HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 25 MG, 2X/DAY 0 25 MG BID
108536735 10853673 12 C HYDROCHLOROTHIAZIDE. HYDROCHLOROTHIAZIDE 1 25 MOL, 2X/DAY 0 25 MOL BID
108536735 10853673 13 C ASPIRIN. ASPIRIN 1 Oral 325 MG, 1X/DAY AT NIGHT 0 325 MG QD
108536735 10853673 14 C ASPIRIN. ASPIRIN 1 Oral 325 MG, 1X/DAY 0 325 MG QD
108536735 10853673 15 C NORTRIPTYLINE NORTRIPTYLINE 1 25 MG, 1X/DAY(AT NIGHT) 0 25 MG QD
108536735 10853673 16 C NORTRIPTYLINE NORTRIPTYLINE 1 20 MG, UNK 0 20 MG
108536735 10853673 17 C FISH OIL FISH OIL 1 Oral 1200 MG, 3X/DAY 0 1200 MG TID
108536735 10853673 18 C FISH OIL FISH OIL 1 Oral UNK, 2X/DAY 0 BID
108536735 10853673 19 C D-3 CHOLECALCIFEROL 1 2000 IU, UNK 0 2000 IU
108536735 10853673 20 C GREEN TEA EXTRACT 2 Oral 630 MG, 1X/DAY 0 630 MG CAPSULE QD
108536735 10853673 21 C GREEN TEA EXTRACT 2 Oral 340 MG, 2X/DAY 0 340 MG CAPSULE BID
108536735 10853673 22 C VITAMIN B12 CYANOCOBALAMIN 1 Oral 2500 UG, 1X/DAY 0 2500 UG QD
108536735 10853673 23 C VITAMIN B12 CYANOCOBALAMIN 1 Oral 150 MG, 2X/DAY 0 150 MG BID
108536735 10853673 24 C FIBER PSYLLIUM HUSK 1 Oral 0.52 G, 2X/DAY 0 .52 G CAPSULE BID
108536735 10853673 25 C FIBER PSYLLIUM HUSK 1 Oral 0.52 MG, 2X/DAY 0 .52 MG CAPSULE BID
108536735 10853673 26 C CAYENNE PEPPER CAPSICUM 1 Oral 2X/DAY (40,000 STUS CAPSULES) 0 CAPSULE BID
108536735 10853673 27 C CAYENNE PEPPER CAPSICUM 1 0 CAPSULE
108536735 10853673 28 C BENAZEPRIL BENAZEPRIL HYDROCHLORIDE 1 20 MG, UNK 0 20 MG
108536735 10853673 29 C ALLOPURINOL. ALLOPURINOL 1 Oral 100 MG, 1X/DAY 0 100 MG QD
108536735 10853673 30 C POTASSIUM CITRATE. POTASSIUM CITRATE 1 Oral 1080 MG, UNK 0 1080 MG
108536735 10853673 31 C CENTRUM VITAMINS 1 1 DF, DAILY 0 1 DF
108536735 10853673 32 C CENTRUM VITAMINS 1 UNK, 2X/DAY 0 BID
108536735 10853673 33 C CALCIUM VITAMIN D CALCIUMVITAMIN D 1 Oral 650 MG, 1X/DAY 0 650 MG QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
108536735 10853673 1 Neuropathy peripheral
108536735 10853673 2 Diabetic neuropathy
108536735 10853673 3 Bladder disorder
108536735 10853673 4 Dysuria
108536735 10853673 5 Blood cholesterol abnormal
108536735 10853673 7 Thyroid disorder
108536735 10853673 8 Diabetes mellitus
108536735 10853673 11 Nephrolithiasis
108536735 10853673 13 Cerebrovascular accident
108536735 10853673 14 Cerebrovascular accident prophylaxis
108536735 10853673 15 Neuropathy peripheral
108536735 10853673 17 Cerebrovascular accident
108536735 10853673 18 Gout
108536735 10853673 19 Immune system disorder
108536735 10853673 20 Blood cholesterol abnormal
108536735 10853673 22 Immune system disorder
108536735 10853673 24 Bowel movement irregularity
108536735 10853673 26 Blood disorder
108536735 10853673 27 Coagulopathy
108536735 10853673 29 Gout
108536735 10853673 30 Renal lithiasis prophylaxis
108536735 10853673 31 Supplementation therapy

Outcome of event

Event ID CASEID OUTC COD
108536735 10853673 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
108536735 10853673 CSF test abnormal
108536735 10853673 Condition aggravated
108536735 10853673 Gout
108536735 10853673 Insomnia
108536735 10853673 Memory impairment
108536735 10853673 Nephrolithiasis
108536735 10853673 Neuropathy peripheral
108536735 10853673 Pain
108536735 10853673 Tremor

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
108536735 10853673 1 2014 0
108536735 10853673 4 2006 0
108536735 10853673 6 2006 0
108536735 10853673 7 1985 0
108536735 10853673 9 2006 0
108536735 10853673 12 2006 0
108536735 10853673 14 2006 0
108536735 10853673 16 2015 0
108536735 10853673 28 2015 0

Execution Time: 0.0048520565032959 seconds (ucode:5181109). Developed by: James D. Barger

 


another James Barger innovation
All original content on this site is © 2013-2024 James D. Barger and SafetyRates.com.